Summary
Stryker Corporation (SYK) announced on November 12, 2020, that it entered into a Term Loan Agreement on November 10, 2020. This agreement provides access to an aggregate principal amount of $400 million, with a maturity date of November 10, 2023. The company fully drew the $400 million on the closing date. This action suggests a strategic use of debt financing, potentially for working capital needs, operational expenditures, or to support future growth initiatives following the acquisition of Wright Medical Group, which closed earlier in the year. Key terms of the loan include covenants related to the company's leverage ratio, with specific thresholds for the period after December 31, 2020. Notably, the agreement allows for an increase in the permitted leverage ratio by 0.5 to 1.0 during an 'acquisition holiday' for up to two four-quarter periods in connection with material acquisitions, indicating flexibility for future M&A activities. The interest rates are tied to LIBOR or a Base Rate plus applicable margins, influenced by credit ratings, reflecting standard market terms.
Key Highlights
- 1Stryker entered into a $400 million Term Loan Agreement on November 10, 2020.
- 2The loan has a maturity date of November 10, 2023.
- 3Stryker fully borrowed the $400 million on the closing date.
- 4The agreement includes financial covenants based on a leverage ratio, with varying limits.
- 5A provision for an 'acquisition holiday' allows for a higher leverage ratio for up to two four-quarter periods in connection with material acquisitions.
- 6Interest rates are variable, based on LIBOR or Base Rate plus applicable margins.
- 7The loan agreement contains substantially similar representations, warranties, covenants, and events of default as existing credit facilities.